Remote DSMB Physician - Early-Phase Biologic Safety Lead

Sitero LLC; Miami (FL); Remote; USD 180,000 - 240,000; Part time

Job summary

Sitero LLC is seeking a physician with proven experience on data and safety monitoring boards to join our remote- based governance team. The role focuses on early-phase biologic safety oversight and ethical review across multiple studies.

You will review protocols, monitor safety signals, and provide risk-based recommendations. This contractor position emphasizes independence from sponsors and collaboration with cross-functional clinical teams.

Qualifications

• Advanced degree or equivalent in science or medicine.
• Experience in early-phase biologic safety oversight.
• Experience with allogeneic, cell-based, or EV therapies.
• Experience chairing Phase I safety reviews.
• Immunology background with immune-mediated events.

Responsibilities

• Review research submissions for regulatory and ethical compliance.
• Prepare for and actively participate in scheduled meetings.
• Evaluate risks, benefits, and safeguards within research protocols.
• Identify non-compliance, protocol deviations, or safety concerns.
• Maintain confidentiality of sensitive research information.
• Provide recommendations for approval, modification, suspension, or termination of studies.
• Document reviews and determinations in accordance with institutional policies.
• Remain current with applicable regulations, guidance, and best practices.
• Complete required training and conflict-of-interest disclosures.

Skills

DSMB experience

Independent oversight

Immunology expertise

Regulatory knowledge

Education

Advanced degree in science/medicine

Job description

Sitero LLC is seeking a physician with proven experience on data and safety monitoring boards to join our remote- based governance team. The role focuses on early-phase biologic safety oversight and ethical review across multiple studies.

You will review protocols, monitor safety signals, and provide risk-based recommendations. This contractor position emphasizes independence from sponsors and collaboration with cross-functional clinical teams.